alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Fourth Court of Appeals

San Antonio, Texas

JUDGMENT

No. 04-20-00583-CV

Kevin DOTY and Elizabeth Doty,

Appellants

v.

Richard DAVIDSON and Javline Ranch (a General Partnership), a/k/a Javelin Ranch, a/k/a 

Javelin Ranch, LP,

Appellees

From the 229th Judicial District Court, Jim Hogg County, Texas

Trial Court No. CC-15-100

Honorable Leonel Alejandro, Judge Presiding

BEFORE CHIEF JUSTICE MARTINEZ, JUSTICE ALVAREZ, AND JUSTICE RODRIGUEZ

In accordance with this court’s opinion of this date, we AFFIRM the trial court’s order 

denying appellants’ motion for summary judgment on limitations and standing/capacity. We 

REVERSE the trial court’s order granting appellees’ motion for summary judgment concerning 

ownership of the Ranch and REMAND appellees’ claims to the trial court for further proceedings. 

It is ORDERED that each party shall bear their own costs of this appeal. 

SIGNED June 29, 2022.

_____________________________

Rebeca C. Martinez, Chief Justice
EXHIBIT 31.02



Certification of Robert M. Kline, Chief Financial Officer, pursuant to

Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended



I, Robert M. Kline, certify that:



1.

I have reviewed this quarterly report on Form 10-Q of Gold Star Tutoring Services, Inc. for the quarterly period ended June 30, 2009;



2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(b)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(c)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and



5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):



(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and



(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



July 31, 2009

/s/Robert M. Kline__________________

Robert M. Kline, Treasurer

Chief Financial Officer

Principal Accounting and Financial Officer
Exhibit 32.2

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the
undersigned, as chief financial officer of AGY Holding Corp. (the Company), does hereby certify that to the undersigneds knowledge:

1) the Companys quarterly report on Form 10-Q for the quarter ended March 31, 2010 fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

2) the information contained in the Companys quarterly report on Form 10-Q for the
quarter ended March 31, 2010 fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                                   
|-----------------------------------
|/s/ Catherine A. Cuisson           
|Catherine A. Cuisson               
|VP of Finance, Corporate Controller
|(Principal Financial Officer)      
|                                   
|Dated: May 14, 2010                

A signed original of this written
statement required by Section 906 has been provided to AGY Holding Corp. and will be retained by AGY Holding Corp. and furnished to the Securities and Exchange Commission or its staff upon request.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Heart, Lung, and Blood Initial Review Group, Clinical Trials Review Committee.                    

*Date:*                         February 26-27, 2007.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Intercontinental Harbor Courtyard Baltimore, 550 Light Street, Baltimore, MD 20202.                    

*Contact Person:*                         Patricia A. Haggerty, PhD, Section Chief, Clinical Studies and Training Scientific Review Group, Review Branch, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, NIH, 6701 Rockledge Drive, Room 7194, MSC 7924, Bethesda, MD 20892, 301/435-0288,                         *haggertp@nhlbi.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: January 4, 2007.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 07-97  Filed 1-11-07; 8:45 am]

BILLING CODE 4140-01-M
| 1. | Such      Quarterly Report on Form 10-Q for the period ending June 30,      2009, fully complies with the requirements of section 13(a) or 15(d) of      the Securities Exchange Act of 1934;and |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | The      information contained in such Quarterly Report on Form 10-Q for      the period ending June 30, 2009, fairly presents, in all      material respects, the financial condition and results of operations of      Formulawon, Inc. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:      August 3, 2009 |
|---------------------------|

| By:    | /s/      Fitra Iriani                                                                                                                          |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------|
|   | Fitra      Iriani                                                                                                                              |
|   | Chairman      of the Board of Directors,Chief      Executive Officer,Chief      Financial Officer,Controller,      Principal AccountingOfficer |
Update on SEC‐0068 Pantex P

Stuart Hinnefeld

Director

National Institute for Occupational Safety and Health

Division of Compensation Analysis and Support

September 2012

Denver, CO
Petition Status

 The petitioned class (after consult call with

NIOSH) was ‘all workers who worked in all

facilities at Pantex from 1/1/51 to 12/31/9

 NIOSH initial decision that petition did not

qualify was reversed by Administrative Re

 The evaluated class was ‘all employees wh

worked in any facility/location at Pantex fr

1/1/51 to 12/31/91’
Petition Status—cont.

 At its November 2011 meeting the Board

recommended adding a class for all worke

from 1/1/58 to 12/31/83 based on infeasib

of reconstructing internal doses from uran

accordance with recommendation from th

Pantex Work Group

 The NIOSH ER had proposed that internal d

from uranium could be bounded by the do

received during dismantlement of the W28weapon system, considered the “dirtiest”
Petition Status—cont.

 W28 dismantlement began in 1984;

dismantlement activities were suspended 

1989

 Some months after the suspension of

dismantlement activities uranium bioassay

samples were collected from workers who 

worked on W28 dismantlement

 NIOSH ER proposed that data set could be 

to calculate bounding internal doses to ura
Petition Status—cont.

 Prior to the November 2012 Board meetin

Pantex Work Group concluded that workconditions and controls were not sufficienstatic at Pantex from 1958 through the lat

1980s to permit doses from W28 dismant

to be instructive about doses from earlieroperations, so they recommended the addof the 1958‐1983 class

 The Work Group took no position on the 1

1989, 1990‐1991, or 1951‐1957 periods
Petition Status—cont.

 1951 to 1957

• Early Pantex operations mainly involved high explo

work. 1958 was chosen as start date for recommen

class because radioactive components were clearly 

handled at Pantex at that time. However, earlier whave involved some radioactive materials, so some

additional investigation is required for this period.

 1984‐1989

• For months NIOSH has searched for records that w

allow more precise interpretation of the W28 bioadata. On Sep 5, 2012, Pantex point of contact emai

the records NIOSH was seeking might have been lo
Petition Status—cont.

 1990‐1991

• NIOSH has access to roughly 1000 uranium bioas

samples from this period, each analyzed isotopic

U‐234, U‐235, U‐236, and U‐238. While the analy

these data are not complete, NIOSH contends th

will prove sufficient to estimate internal doses d

uranium during this period.
<PAGE>
Exhibit 99.2

                    PRINCIPAL FINANCIAL OFFICER CERTIFICATION
            PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report of Vita Food Products, Inc. (the
"Company"), on Form 10-K for the fiscal year ended December 31, 2002, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
the undersigned, in the capacity and on the date indicated below, hereby
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that: (1) the Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and (2) the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.



Date:  March 31, 2003                       /s/ Clifford K. Bolen
                                            ------------------------------------
                                                    Clifford K. Bolen,
                                                 Executive Vice President;
                                                  Chief Financial Officer
                                               (Principal Financial Officer)
Exhibit 32

ISONICS CORPORATION

Certification pursuant to 18 U.S.C. §1350  Principal Executive Officer

To my knowledge: the annual report on Form 10-KSB for the year ended April 30, 2003, containing financial statements for the year then
ended, fully complies with the requirements of Section 13(a) of the Securities Act of 1934; and the information contained in the Form 10-KSB fairly presents, in all
material respects, the financial condition and results of operations of Isonics Corporation for the periods presented.

August 12,
2003

|/s/JAMES E. ALEXANDERJames E. Alexander, Chief Executive Officer |  |  |  | 
|---------------------------------------------------------------- |  |  |  | 

Certification pursuant to 18 U.S.C. §1350  Principal Financial Officer

To my knowledge: the annual report on Form 10-KSB for the year ended April 30, 2003, containing financial statements for the year then
ended, fully complies with the requirements of Section 13(a) of the Securities Act of 1934; and the information contained in the Form 10-KSB fairly presents, in all
material respects, the financial condition and results of operations of Isonics Corporation for the periods presented.

August 12,
2003

|/s/JOHN SAKYSJohn Sakys, Chief Financial Officer |  |  |  | 
|------------------------------------------------ |  |  |  | 

---

QuickLinks
<PAGE>
 
                                                                    EXHIBIT 23.1


                       CONSENT OF INDEPENDENT ACCOUNTANTS
                                        
   We consent to the incorporation by reference in the registration statements
of Inktomi Corporation on Form S-8 (File Number 333-66217) of our report dated
October 16, 1998, on our audits of the consolidated financial statements of
Inktomi Corporation and its subsidiaries as of September 30, 1997 and 1998 and
for the period from February 2, 1996 (date of inception) to September 30, 1996
and the years ended September 30, 1997 and 1998, which report is included in
this Annual Report on Form 10-K.


                    /s/ PricewaterhouseCoopers LLP


San Francisco, California
December 16, 1998
[Federal Register Volume 73, Number 22 (Friday, February 1, 2008)]
[Notices]
[Page 6191]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-432]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, ``The Mucosal Immune Barrier''.
    Date: February 27, 2008.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, Rm. 
3256, Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Ileana M. Ponce-Gonzalez, MD, MPH, Scientific 
Review Officer, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, (301) 451-3679, 
<a href="/cdn-cgi/l/email-protection#472e372028293d262b223d07292e262e2369292e2f69202831"><span class="__cf_email__" data-cfemail="c7aeb7a0a8a9bda6aba2bd87a9aea6aea3e9a9aeafe9a0a8b1">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 25, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-432 Filed 1-31-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# C_2011176EN.01000101.xml

| 16.6.2011 | EN | Official Journal of the European Union | C 176/1 |
| --- | --- | --- | --- |

16.6.2011

EN

Official Journal of the European Union

C 176/1

---

Euro exchange rates (1)

1

15 June 2011

2011/C 176/01

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,4292 |
| JPY | Japanese yen | 115,54 |
| DKK | Danish krone | 7,4591 |
| GBP | Pound sterling | 0,87970 |
| SEK | Swedish krona | 9,1482 |
| CHF | Swiss franc | 1,2164 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 7,8200 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 24,215 |
| HUF | Hungarian forint | 265,85 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7089 |
| PLN | Polish zloty | 3,9410 |
| RON | Romanian leu | 4,1720 |
| TRY | Turkish lira | 2,2811 |
| AUD | Australian dollar | 1,3387 |
| CAD | Canadian dollar | 1,3862 |
| HKD | Hong Kong dollar | 11,1306 |
| NZD | New Zealand dollar | 1,7574 |
| SGD | Singapore dollar | 1,7642 |
| KRW | South Korean won | 1 548,35 |
| ZAR | South African rand | 9,7231 |
| CNY | Chinese yuan renminbi | 9,2644 |
| HRK | Croatian kuna | 7,3995 |
| IDR | Indonesian rupiah | 12 217,93 |
| MYR | Malaysian ringgit | 4,3405 |
| PHP | Philippine peso | 62,180 |
| RUB | Russian rouble | 39,9470 |
| THB | Thai baht | 43,633 |
| BRL | Brazilian real | 2,2717 |
| MXN | Mexican peso | 16,9239 |
| INR | Indian rupee | 63,9710 |

Currency

Exchange rate

USD

US dollar

1,4292

JPY

Japanese yen

115,54

DKK

Danish krone

7,4591

GBP

Pound sterling

0,87970

SEK

Swedish krona

9,1482

CHF

Swiss franc

1,2164

ISK

Iceland króna

NOK

Norwegian krone

7,8200

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

24,215

HUF

Hungarian forint

265,85

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7089

PLN

Polish zloty

3,9410

RON

Romanian leu

4,1720

TRY

Turkish lira

2,2811

AUD

Australian dollar

1,3387

CAD

Canadian dollar

1,3862

HKD

Hong Kong dollar

11,1306

NZD

New Zealand dollar

1,7574

SGD

Singapore dollar

1,7642

KRW

South Korean won

1 548,35

ZAR

South African rand

9,7231

CNY

Chinese yuan renminbi

9,2644

HRK

Croatian kuna

7,3995

IDR

Indonesian rupiah

12 217,93

MYR

Malaysian ringgit

4,3405

PHP

Philippine peso

62,180

RUB

Russian rouble

39,9470

THB

Thai baht

43,633

BRL

Brazilian real

2,2717

MXN

Mexican peso

16,9239

INR

Indian rupee

63,9710

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

BOARD OF SUPERVISORS OF

WILLISTOWN TOWNSHIP,

Respondent

v.

MAIN LINE GARDENS, INC. AND

COFFMAN ASSOCIATES, LLC,

Petitioners :

:

:

:

:

:

:

:

:

:

:

:

: No. 371 MAL 2018

Petition for Allowance of Appeal from

the Order of the Commonwealth Court

BOARD OF SUPERVISORS OF

WILLISTOWN TOWNSHIP,

Respondent

v.

MAIN LINE GARDENS, INC. AND

COFFMAN ASSOCIATES, LLC,

Petitioners :

:

:

:

:

:

:

:

:

:

:

:

: No. 372 MAL 2018

Petition for Allowance of Appeal from

the Order of the Commonwealth Court

BOARD OF SUPERVISORS OF

WILLISTOWN TOWNSHIP,

Respondent

v.

MAIN LINE GARDENS, INC. AND

COFFMAN ASSOCIATES, LLC,

Petitioners :

:

:

:

:

:

:

:

:

:

:

:

: No. 373 MAL 2018

Petition for Allowance of Appeal from

the Order of the Commonwealth Court[ 371 MAL 2018, 372 MAL 2018, 373 MAL 2018, 374 MAL 2018, 375 MAL 2018 and 376

MAL 2018 ]

- 2 BOARD OF SUPERVISORS OF

WILLISTOWN TOWNSHIP,

Respondent

v.

MAIN LINE GARDENS, INC. AND

COFFMAN ASSOCIATES, LLC,

Petitioners :

:

:

:

:

:

:

:

:

:

:

:

: No. 374 MAL 2018

Petition for Allowance of Appeal from

the Order of the Commonwealth Court

BOARD OF SUPERVISORS OF

WILLISTOWN TOWNSHIP,

Respondent

v.

MAIN LINE GARDENS, INC. AND

COFFMAN ASSOCIATES, LLC,

Petitioners :

:

:

:

:

:

:

:

:

:

:

:

: No. 375 MAL 2018

Petition for Allowance of Appeal from

the Order of the Commonwealth Court

BOARD OF SUPERVISORS OF

WILLISTOWN TOWNSHIP,

Respondent

v.

MAIN LINE GARDENS, INC. AND

COFFMAN ASSOCIATES, LLC,

Petitioners :

:

:

:

:

:

:

:

:

:

:

:

: No. 376 MAL 2018

Petition for Allowance of Appeal from

the Order of the Commonwealth Court

ORDER[ 371 MAL 2018, 372 MAL 2018, 373 MAL 2018, 374 MAL 2018, 375 MAL 2018 and 376

MAL 2018 ]

- 3 PER CURIAM

AND NOW , this 29th day of October, 2018

, the Petition for Allowance of Appeal is

DENIED

.
**Exhibit
      23.1**





**CONSENT
      OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**





We
      have
      issued our report dated September 18, 2008, accompanying the consolidated
      financial statements included in the Annual Report of SMF Energy Corporation
      on
      Form 10-K for the year ended June 30, 2008.  We hereby consent to the
      incorporation by reference of said reports in the Registration Statements of
      SMF
      Energy Corporation on Forms S-8 (File Nos. 333-79801, 333-61764, 333-113622,
      and
      333-126123) and on Forms S-3 (File Nos. 333-61762, 333-113682, 333-126116,
      333-131146, 333-143577, 333-148217, and 333-151270).




/s/
      Grant
      Thornton LLP





Fort
      Lauderdale, Florida


September
      18, 2008